The short version of storage stability fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-09-23 and is reviewed periodically as new material appears.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for research-grade material |
| Solubility | Soluble in DMSO and ethanol; low aqueous solubility | Organic stock solutions are common |
| Typical storage temperature | -20 °C or lower | Protect from light and moisture |
| Common analytical method | LC-MS/MS | Used for detection and confirmation |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
==== First state of emergency: July 1985 ==== On 20 July 1985, President Botha declared a partial state of emergency, effective from midnight, which he said would hold indefinitely in 36 townships around Johannesburg and in the eastern Cape. It was the first state of emergency since that imposed after the 1960 Sharpeville massacre, although a different variety of emergency regulation had also been imposed after the 1976 Soweto uprising. The death toll of the uprising was at that point estimated at 450 fatalities, and Botha said the emergency would combat "acts of violence and thuggery... mainly directed at the property and person of law-abiding black people". In a statement, he said:I wish to give the assurance that law-abiding people have nothing to fear. At the same time, I wish to issue a warning that strict action will be taken against those persons and institutions that cause or propagate disruption.The order gave the police and military "virtually unlimited" powers of search-and-seizure and arrest, as well as powers to seal off, impose curfews on, and censor news from the affected areas. During the first week, 1,000 activists were detained in the affected areas, and 16 people were killed. Despite the emergency, unrest continued in the Transvaal and eastern Cape and worsened elsewhere, particularly in Natal and the western Cape.
The most recognizable and most common form of dwarfism in humans is achondroplasia, which accounts for 70% of dwarfism cases, and occurs in 4 to 15 out of 100,000 live births. It produces rhizomelic short limbs, increased spinal curvature, and distortion of skull growth. In achondroplasia the body's limbs are proportionately shorter than the trunk (abdominal area), with a larger head than average and characteristic facial features. Achondroplasia is an autosomal dominant disorder caused by the presence of an altered allele in the genome. If a pair of achondroplasia alleles are present, the result is fatal, usually perinatally. Achondroplasia is a mutation in the fibroblast growth factor receptor 3. In the context of achondroplasia, this mutation causes FGFR3 to become constitutively active, inhibiting bone growth.
Overall, understanding and managing radiation damping is crucial for obtaining high-quality NMR data, especially in modern high-field spectrometers where the effects can be significant due to the increased sensitivity and resolution.
advanced age cigarette smoking hypertension (high blood pressure) obesity hyperlipidemia, e.g. hypercholesterolemia, hypertriglyceridemia, elevated lipoprotein (a) or apolipoprotein B, or decreased levels of HDL cholesterol) diabetes mellitus Sedentary lifestyle stress Other important risk factors for arterial embolism include:
The new 22nd district encompasses the southwest suburban corner of the Greater Houston metropolitan area across Harris, Fort Bend and Brazoria counties, including the southern Houston suburbs of Sugar Land, Rosenberg, Lake Jackson and Angleton, as well as the Katy and Fulshear areas in both Harris and Fort Bend counties. The incumbent is Republican Troy Nehls, who is not seeking reelection and was re-elected with 62.1% of the vote in 2024. That same year, Donald Trump won 59.9% and Ted Cruz 56.9% of the vote in the district, which is diverse with double-digit populations of White, Hispanic, Asian and Black residents (both voting age and overall).
Sources: en.wikipedia.org
=== Types === The ABO blood group system was discovered in the year 1900 by Karl Landsteiner. Jan Janský is credited with the first classification of blood into the four types (A, B, AB, and O) in 1907, which remains in use today. In 1907 the first blood transfusion was performed that used the ABO system to predict compatibility. The first non-direct transfusion was performed on 27 March 1914. The Rhesus factor was discovered in 1937.
A modified variant of the atractylenolide carries an additional carboxyl group at the C4 atom of the atractyligenin, which is then referred to as carboxy-atractyloside (CATR), sometimes referred to as "gummiferin". The ATR/CATR chemical structure on the right indicates this difference between compounds.
The concept of in situ in contemporary art developed in the late 1960s and 1970s, referring to works created for a specific site. Such works incorporate the site's physical, historical, political, and sociological characteristics as integral elements of their composition. This approach contrasts with autonomous artistic production, where artworks are conceived independently of their display location. Theoretical discussions, particularly in the writings and practice of French conceptual artist and sculptor Daniel Buren, have addressed the dynamic relationship between artistic intervention and its surrounding environment. The site-specific installations of Christo and Jeanne-Claude exemplify the application of in situ principles in art. Their large-scale interventions such as The Pont Neuf Wrapped (1985) and Wrapped Reichstag (1995) involved the systematic wrapping of buildings and landscape elements in fabric, temporarily transforming familiar spaces and altering public perception. Another example is the land art movement, wherein artists such as Robert Smithson and Michael Heizer integrated their works directly into natural landscapes. In contemporary aesthetic discourse, in situ describes practices that reinforce the fundamental unity between an artwork and its site.
Tools were initially developed by hominids through observation and trial and error. Around 2 mya (million years ago), they learned to make the first stone tools by hammering flakes off a pebble, forming a sharp hand axe. This practice was refined 75 kya (thousand years ago) into pressure flaking, enabling much finer work. The discovery of fire was described by Charles Darwin as "possibly the greatest ever made by man". Archaeological, dietary, and social evidence point to "continuous [human] fire-use" at least 1.5 mya. Fire, fueled with wood and charcoal, allowed early humans to cook their food to increase its digestibility, improving its nutrient value and broadening the number of foods that could be eaten. The cooking hypothesis proposes that the ability to cook promoted an increase in hominid brain size, though some researchers find the evidence inconclusive. Archaeological evidence of hearths was dated to 790 kya; researchers believe this is likely to have intensified human socialization and may have contributed to the emergence of language. Other technological advances made during the Paleolithic era include clothing and shelter. No consensus exists on the approximate time of adoption of either technology, but archaeologists have found archaeological evidence of clothing 90-120 kya and shelter 450 kya. As the Paleolithic era progressed, dwellings became more sophisticated and more elaborate; as early as 380 kya, humans were constructing temporary wood huts.
During visits to the Middle East by Pope John Paul II, Pope Benedict XVI, and Pope Francis, they met with Druze religious leaders alongside leaders of other faiths. The Vatican Library houses several Druze manuscripts, mainly volumes of the Epistles of Wisdom (Rasa'il al-Hikmah), dating back to the 10th and 11th centuries. In modern times, Druze religious and political delegations have made visits to the Vatican City. Mowafaq Tarif, the spiritual leader of the Druze in Israel, attended the funerals of Pope John Paul II in 2005 and Pope Benedict XVI in 2023, representing the Druze community. In 2022, Mowafaq Tarif visited the Vatican City and met with Pope Francis. During this meeting, both leaders emphasized the importance of religious coexistence between Christians and Druze. They also stressed the need for religious organizations active in Syria and Lebanon to provide and intensify humanitarian aid to all populations and regions, including Druze areas.
Sources: en.wikipedia.org
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.
Liquid chromatography with tandem mass spectrometry is widely used to detect and confirm SR9009 in laboratory samples. The technique offers high sensitivity and can distinguish the target compound from related substances. Nuclear magnetic resonance and ultraviolet detection may support identity and purity checks.
Online products labeled as SR9009 may vary in identity, purity, and actual content. Independent testing helps confirm that a sample matches its label and does not contain unexpected contaminants. This is important for reproducible research and for interpreting experimental results.
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.